The bank puts the three countries' weight loss drug market at $6.6 billion today and expects cheaper prices and wider access to drive the growth.
Recap by typeshit. Full story at Miami Herald.
Medicare open enrollment has started, and plan changes include newly negotiated drug prices and lower costs on some medications.
Prescriptions roll out in phases from the 29th, starting at 129,800 won for four weeks. Hanmi reported 9.75% average weight loss at 40 weeks in a phase 3 interim analysis.
Parker argues patients can spend two weeks fighting for coverage of one GLP-1 without learning another brand might cost them nothing.
Millions of Medicare beneficiaries may want in on the GLP-1 Bridge program, but eligibility rules mean not everyone will qualify.
Panelists narrowly voted yes on six of seven peptides despite FDA scientists urging no. Emideltide was rejected, and the agency still has the final say.
Dr Ahmad Rehan Khan shares a Semenza and Thomas paper in Criminology that surveyed 821 US adults on weight-loss drug use and violent behavior.
Loading…